To boost the business and investment climate in Cambodia, Ministry of Health (commonly referred as βMOHβ) releases a new directive for the pharmaceutical manufacturing institution and pharmaceutical import-export institution, namely βDirective No. 5410 On the Application for A Permit of Import and Export Health Products Under the National Single Window.β dated 1 November 2024, (βDirective No. 5410β) to submit an electronic application via online system and begin to practice early next year.
- Whatβs New?
From 1 January 2025 onwards, the business owners of pharmaceutical manufacturing institutions and pharmaceutical import-export institutions shall begin to apply for a permit to import and export health products through the National Single Window.
- Highlight of Key Takeaway
For the convenience of the business owners associated with pharmaceutical manufacturing institutions and pharmaceutical import-export institutions, the MOH officially announced and shared a short video clip instructing how to submit and request a permit to import and export health products through an electronic application.
- Enforcement
The business owner of pharmaceutical manufacturing institution and pharmaceutical import-export institution shall exercise effectively and respectively this Directive No. 5410 from 1 January 2025 onwards.
For additional information, please contact our legal expert Solina YEAN orΒ Antoine FONTAINE
The content shared here is for informational purposes only and should not be interpreted as a legal advice. Legal matters can be complex and may vary based on individual circumstances. For personalized guidance on specific legal issues, we recommend consulting with our qualified legal professionals.